Skip to main content
main-content

06.01.2018 | Original Article | Ausgabe 2/2018

International Journal of Legal Medicine 2/2018

Acute phase response after fatal traumatic brain injury

Zeitschrift:
International Journal of Legal Medicine > Ausgabe 2/2018
Autoren:
Benjamin Ondruschka, Sandra Schuch, Dirk Pohlers, Heike Franke, Jan Dreßler
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00414-017-1768-2) contains supplementary material, which is available to authorized users.
Benjamin Ondruschka and Sandra Schuch contributed equally to this work.

Abstract

An inflammatory response occurring after fatal traumatic brain injury (TBI) initiates time-dependent cascades of acute phase response. This may offer the potential to monitor postmortem biomarker levels of several pro-inflammatory cytokines to gain information about the cause of death and the trauma survival time. Cerebrospinal fluid (CSF) and serum samples were collected from forensic autopsies of 95 adult cadavers after postmortem intervals up to 6 days. The cases were divided according to their cause of death into fatal TBI (n = 46) with different survival times and age- and gender-matching non-TBI fatalities as controls (n = 49). Quantitative marker levels of interleukin-6 (IL-6), ferritin, soluble tumor necrosis factor receptor type 1, C-reactive protein, and lactate dehydrogenase were analyzed using immunoassays. Standardized statistical tests were performed to differentiate causes of death and survival time of TBI cases. The CSF IL-6, ferritin, and LDH levels after TBI were significantly higher than those in the controls (p < 0.001). Only serum IL-6 values showed comparable differences (p < 0.05). Both CSF and serum ferritin levels were discriminative between early and delayed death after TBI (p < 0.05). There were partly distinctive correlations between marker levels in both fluids with rising values after longer survival. There were up to moderate correlation between the marker levels and the postmortem interval due to postmortem hemolysis. However, neither CSF nor serum level ranges were affected by the age or gender of the subjects. This study is the first to measure all five proteins systematically in postmortem trauma cases. Ferritin and IL-6 proved themselves to be interesting postmortem biomarkers to provide specific information on the injury pattern and the survival time of traumatic fatalities. Such forensic investigations could serve as inexpensive and fast laboratory tests.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Zusatzmaterial
Table S1: Clinical and pathological characteristics of the individuals died from traumatic brain injury. ISS, injury severity score; GCS, Glasgow coma scale; CPR, cardiopulmonary resuscitation; g; grams; h, hours; PMI, postmortem interval; TBI, traumatic brain injury; w, women; m, men; sec, seconds; min, minutes; d, days; n.d., no documentation. (XLSX 15 kb)
414_2017_1768_MOESM1_ESM.xlsx
Table S2: Clinical and pathological characteristics of the individuals served as control cases. ISS, injury severity score; CPR, cardiopulmonary resuscitation; g; grams; h, hours; PMI, postmortem interval; w, women; m, men; min, minutes. (XLSX 13 kb)
414_2017_1768_MOESM2_ESM.xlsx
Table S3: Results of rank correlation calculation between the five markers of acute phase response and the hemolytic index as well as the postmortem interval in cerebrospinal fluid (CSF) and serum. (XLS 32 kb)
414_2017_1768_MOESM3_ESM.xls
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 2/2018

International Journal of Legal Medicine 2/2018 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

14.03.2019 | Originalien | Ausgabe 2/2019

Medikamentennachweise bei bayerischen Altenheimbewohnern – eine rechtsmedizinische Analyse

Erste Ergebnisse aus Screeninguntersuchungen an Urinproben

07.03.2019 | Mammakarzinom | CME | Ausgabe 2/2019

Update der S3-Leitlinie Mammakarzinom

Was gibt es Neues für Pathologen?

21.02.2019 | Schwerpunkt: Neuropathologie | Ausgabe 2/2019

Neuropathologie der Medulloblastome und anderer embryonaler Tumoren des ZNS

Präzisierung der Diagnostik durch Integration genetischer Marker